baber/WOPTO huggingface dataset:
Patent HR-P20110708-T1 (HR)
Title: Sulfite/sulfate-oxidation accelerator unit
Inventor: KEHRMANN KAI MATTHIAS
IPC: B01D53/50
Filed: 2011-10-05
Abstract: The accelerator unit has an accelerator provided in form of a three-dimensional body (10) passed through sea water. The body is assembled in a cover (30), which is passed through the sea water. The body and the cover are designed in such a manner that the body remains in the cover during predominant flow of the sea water. The cover comprises a fabric, a knitted fabric, a mesh, a grid and a membrane, and is formed in shape of ball, pyramid, cube, tube and sack. The cover is made of metal or plastic.
Patent SI-1388724-T1 (SI)
Title: Land mine clearing system
Inventor: JENNEQUIN GERARD
IPC: F41H11/16
Filed: 2003-07-03
Abstract: Land mine clearing system consists of pilot vehicle (3), and series of land mine clearing vehicles (4) preceding vehicle at head of convoy (1). Pilot vehicle and land mine clearing vehicles are traveling at safe distance from each other, are pilot-less, and remotely controlled from the head vehicle. Land mine clearing vehicles are tri-wheeled vehicles with platform carrying charge necessary to lure land mine igniters.
Patent SI-1515702-T1 (SI)
Title: Abuse-protected administration form
Inventor: BARTHOLOMAUS JOHANNES
IPC: A61K9/00
Filed: 2003-06-16
Abstract: The invention relates to a solid administration form, protected from parenteral abuse and containing at least one viscosity-increasing agent in addition to one or more active substances that have parenteral abuse potential. Said agent forms, when a necessary minimum amount of an aqueous liquid is added, on the basis of an extract obtained from the administration form, a preferably injectable gel that remains visually distinct when introduced into another quantity of an aqueous liquid.
Patent SI-1505973-T1 (SI)
Title: Combinations for treating multiple myeloma
Inventor: ZELDIS JEROME B
IPC: A61K31/4035
Filed: 2003-05-16
Abstract: Methods of treating, preventing and/or managing cancer as well as diseases and disorders associated with, or characterized by, undesired angiogenesis are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active ingredient. The invention further relates to methods of reducing or avoiding adverse side effects associated with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy which comprise the administration of an immunomodulatory compound. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Patent SI-1641775-T1 (SI)
Title: 2-pyridine alkyne derivatives useful for treating pain
Inventor: KYLE DONALD J
IPC: A61K31/00
Filed: 2004-07-01
Abstract: The invention provides a compound of formula (I): (where R1, Q, A and R2 are disclosed herein) or a pharmaceutically acceptable salt thereof (a “Pyridine-alkynyl Compound”); pharmaceutical compositions comprising an effective amount of a Pyridine-alkynyl Compound; and methods for treating or preventing a condition such as pain, urinary incontinence, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, a seizure, stroke, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis, dementia, retinopathy, a muscle spasm, a migraine, vomiting, dyskinesia or depression in an animal comprising administering to an animal in need thereof an effective amount of a Pyridine-alkynyl Compound.
Patent SI-1624891-T1 (SI)
Title: Clotting factor-fc chimeric proteins to treat hemophilia
Inventor: RIVERA DANIEL S
IPC: A61K39/395
Filed: 2004-05-06
Abstract: A pharmaceutical composition, for treatment of a hemostatic disorder, comprises a chimeric protein and a pharmaceutically acceptable carrier or excipient, wherein said chimeric protein comprises at least a portion of an immunoglobulin constant region which is an FcRn binding partner, a clotting factor selected from Factor VII, a Factor VII analog, Factor VIIa and a Factor VIIa analog, and optionally at least one linker.
Patent SI-1843754-T1 (SI)
Title: New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance
Inventor: JERALA-STRUKELJ ZDENKA
IPC: A61K9/20
Filed: 2006-01-24
Abstract: New composition of candesartan cilexetil is prepared using up to 20% of carrageenan which suitably stabilized the active ingredient against degradation during the tableting.
Patent SI-2000465-T1 (SI)
Title: Triazolone derivative
Inventor: CLARK RICHARD
IPC: A61K31/4196
Filed: 2007-03-22
Abstract: A Compound represented by the following general formula (1), salts thereof or hydrates of the foregoing is a novel compound useful for treatment and/or prevention of diseases associated with thrombus formation, and which is safer with suitable physicochemical stability.   
[wherein R 1a , R 1b , R 1c  and R 1d  each independently represent hydrogen, etc.; R 2  represents optionally substituted phenyl, etc.; R 3  represents optionally substituted C6-10 aryl, etc.; and Z 1  and Z 2  each independently represent hydrogen]
Patent SI-2269210-T1 (SI)
Title: Method for measuring gases and corresponding ion mobility spectrometer
Inventor: MATTILA TERHI
IPC: H01J49/00
Filed: 2009-04-02
Abstract: The invention relates to a method and device for measuring gaseous substances, in which the method comprises the stages: ionization of the sample gas in a gas flow, leading of the ionized gas flow through an elongated ion-mobility measuring chamber in the cross-section defined by it, filtering out of ions from the ionized gas flow at a distance from the measuring electrodes, permitting the passage of only the ions travelling from the flow cross-section at the selected point, separation of ions with a different ion mobility, with the aid of a transverse static electric field and at least one measuring-electrode pair arranged along the wall of the measuring chamber.
Patent SI-2943072-T1 (SI)
Title: Methods and compositions for affecting the flavor and aroma profile of consumables
Inventor: FRASER RACHEL
IPC: A23L27/26
Filed: 2014-01-13
Abstract: This document relates to food products containing highly conjugated heterocyclic rings complexed to an iron ion and one or more flavor precursors, and using such food products to modulate the flavor and/or aroma profile of other foods. The food products described herein can be prepared in various ways and can be formulated to be free of animal products.
Patent TR-200302342-T1 (TR)
Title: SüspansiyonÁmekanizması
Inventor: SERKH ALEXANDER
IPC: F16H7/08
Filed: 2003-04-18
Abstract: Bir kayis gericide kullanilmak üzere bir asimetrik süspansiyon mekanizmasi. Süspansiyon mekanizmasi bir gericiyi birlestirmek için esasen benzer kavisli sekillere sahip iki parça içerir. Birinci kisim döner bir temas noktasindan ikinci kisim ile temas halindedir. Temas noktasinin yeri istenilen asimetrik süspansiyon faktörüne göre belirlenir. Birinci kisim ayrica bir yaya temas eder. Ikinci kisim bir gerici kolu ile temas eder. Süspansiyon mekanizmasi ayrica her biri bir süspansiyon bandina sahip olan iki süspansiyon balatasi içerir. Süspansiyon bandi, üzerindeki yivlerle birlikte çalisan süspansiyon balatasi üzerindeki dikey yivler sayesinde süspansiyon balatasina baglanir. Süspansiyon mekanizmasi yaklasik 1.5-5 arasinda bir asimetrik süspansiyon faktörüne sahiptir.
Patent DE-3789883-T2 (DE)
Inventor: BALTIMORE DAVID
IPC: C12Q1/68
Filed: 1987-01-09
Granted: 1994-10-06
Abstract: Constitutive and tissue-specific protein factors which bind to transcriptional regulatory elements of Ig genes (promoter and enhancer). The factors were identified and isolated by an improved assay for protein-DNA binding.
Patent DE-3852636-T2 (DE)
Inventor: BALLARD FRANCIS
IPC: A61P43/00
Filed: 1988-12-20
Granted: 1995-05-04
Abstract: PCT No. PCT/AU88/00485 Sec. 371 Date Aug. 24, 1989 Sec. 102(e) Date Aug. 24, 1989 PCT Filed Dec. 20, 1988 PCT Pub. No. WO89/05822 PCT Pub. Date Jun. 29, 1989.Peptide analogues of insulin-like growth factor 1 and growth factor 2 are disclosed. When the analogue is an analogue of growth factor 1 the glutamic acid residue is absent from position 3 of the N-terminal and either the glutamic acid residue or the threonine residue adjacent to glutamic acid residue at position 3 is replaced by a different amino acid residue. When the peptide analogue is an analogue of insulin growth factor 2 the glutamic acid residue position 5 is absent. Preferred peptide analogues are disclosed. Methods of use in pharmaceutical and veterinary preparations are described.
Patent DE-3855029-T2 (DE)
Inventor: LOADER DAVID B
IPC: G06F9/48
Filed: 1988-06-13
Granted: 1996-09-05
Abstract: The present invention relates to a Transport Mechanism system and method, implemented in software, that permits the coordinated supervision, by an arbitrary number of SUPERVISOR PROGRAMS, of the execution of indirect-addressed interrupt-handling routines in an operating system. The Transport Mechanism intercepts each call to a supervised interrupt handler, creates a MEMORY MODEL of the then-existing environment, and hands control in sequence to the SUPERVISOR PROGRAMS. Each SUPERVISOR PROGRAM can examine the MEMORY MODEL as well as modify it, and can call a Transport Mechanism service routine which results in turn in the calling of the normal IH routine, but now in the context of the environment specified by the MEMORY MODEL. Such execution is followed by return of control to the calling SUPERVISOR PROGRAM. After all called SUPERVISOR PROGRAMS have completed their execution and returned control to the Transport Mechanism, the Transport Mechanism conforms the actual environment to that indicated by the MEMORY MODEL. If no SUPERVISOR PROGRAM has called for execution of the called interrupt, the Transport Mechanism does so. The Transport Mechanism then returns control to the program which originally initiated the interrupt event.
Patent TR-199801321-T2 (TR)
Inventor: GARRAWAY RICHARD
IPC: B26B21/40
Filed: 1997-01-08
Abstract: Bir emniyetli tras biçagi biriminde,bir deriye takilan eleman,bir taban kismindan yukariya dogru uzanan ve üst uçlarinda açik olan aralikli içi bos uzantilar tarafindan olusturulan,tras olma esnasinda deriye temas etmek için bir yüzeye sahiptir.Uzantilar esneyerek bükülebilen malzemeden yapilmistir ve tercihan taban kismi boyunca siralar halinde düzenlenmistir.Uzantilar tercihan boru sekilli olmakla birlikte,her iki yönde,içe ve/veya disa uca dogru daralabilmektedirler.
Patent DE-60001837-T2 (DE)
Inventor: RYAN O
IPC: H04N7/26
Filed: 2000-08-01
Granted: 2003-12-11
Abstract: A robust technique to prevent illicit copying of video information notwithstanding the use of image scaling. A watermark is embedded into the video signal (e.g., DVD's content or other video sources) at different scales (i.e., sizes). The watermark is maintained at each scale for a predetermined time duration that is sufficient to allow the detector circuit in a DVD-recorder, DVHS recorder, DVCR, or any other digital format recorder to detect, extract, and process information contained in the watermark. At the end of the predetermined time duration, the watermark is changed to a different scale preferably on a pseudo-random basis to ensure that each one of all the scales in a predetermined scaling range is achieved a predetermined number of times. Thereby the recorder shuts off a number of times during play of the content, each time the detector circuit senses the watermark.
Patent DE-60008920-T2 (DE)
Inventor: JENG DE-YIN
IPC: C04B35/111
Filed: 2000-11-15
Granted: 2004-07-29
Abstract: Disclosed is a sol-gel process for making high-density monolithic alpha-alumina articles. Cracking problems caused by shrinkage of the gel during the drying and firing stages are minimized by controlling the temperature and humidity during the drying process and by using molds formed of prescribed polymeric materials, preliminarily coated with a silicone release agent. The process of the invention provides porous alpha-alumina articles having a controlled microstructure and a controlled pore size distribution, which are beneficial features when the material is used in practical applications, e.g., as substrates for gas sensors.
Patent DE-60013551-T2 (DE)
Inventor: HAMSTEN BJOERN
IPC: B65G47/68
Filed: 2000-09-12
Granted: 2005-09-29
Abstract: Apparatus for controlling units within a flow from at least one incoming feeder track into at least one outgoing feeder track is provided, including at least one shifting unit for controlled shifting of the flow into one or more selectable paths of the outgoing feeder track, wherein the shifting unit is provided with a speed controller for controlling the speeds of the respective units and separation of the units in the longitudinal direction of flow, the separation enabling the controlled shifting.
Patent DE-60013751-T2 (DE)
Inventor: ADAM MAVIS DIANE
IPC: A61P25/22
Filed: 2000-12-13
Granted: 2005-09-29
Abstract: The present invention relates to optically active 3-Ä(2-piperazinylphenyl)methylÜ-1-Ä4-(trifluoromethyl)phenylÜ-2-pyrrol idinones and pharmaceutically acceptable salts thereof, to processes for their preparation, to isotopically-labeled analogs thereof, to pharmaceutical compositions comprising them and to their medicinal use as selective antagonists of the 5-HTID receptor. The compounds of the invention are useful in treating depression, obsessive-compulsive disorder (OCD) and diseases, disorders or conditions for which a 5-HTID receptor selective antagonist is therapeutically indicated.
Patent DE-60013872-T2 (DE)
Inventor: KELLY ROBERT
IPC: A01N59/06
Filed: 2000-10-19
Granted: 2005-08-18
Abstract: This application relates to antiviral tissue paper comprising a water soluble metal ion as an antiviral agent. The water soluble metal ion has at least one hydroxide ion formation constant wherein the hydroxide ion formation constant is at least 10<12>. When added to tissue the water soluble metal ion has the ability to kill certain strains of viruses which come into contact with the tissue.
Patent DE-60018872-T2 (DE)
Inventor: MOSHER MALCOLM
IPC: G06F11/14
Filed: 2000-10-16
Granted: 2005-07-28
Abstract: A primary computer system has a database, application programs that modify the local database, and a transaction manager that stores audit records in a local image trail reflecting those application program modifications to the local database. In a remote backup system, a Receiver process receives audit records from the primary system. The audit records include audit update and audit backout records indicating database updates and database backouts generated by transactions executing on the primary system. The Receiver stores the audit update and audit backout records in one or more image trails. For each image trail there is an Updater process that applies to a backup database volume the database updates and backouts indicated by the audit update and audit backout records in the image trail. The remote backup system periodically executes a file purge procedure, which identifies the oldest transaction table from among the transaction tables in the last image trail file accessed for each of the image trails. Then, for each image trail, the file purge procedure accesses the image trial files in a predefined chronological order and for each accessed image trail file it compares a first set of newest transaction identifiers in the file's transaction table with a second set of oldest transaction identifiers in the identified oldest transaction table. The procedure purges the accessed image trail file only when all of the transaction identifiers in the first set are older than corresponding transaction identifiers in the second set.
Patent DE-60019259-T2 (DE)
Inventor: LEIGHTON MURRAY EDWARD BRUCE
IPC: B65D33/16
Filed: 2000-09-27
Granted: 2006-02-16
Abstract: A plastics bag has at least one seal ( 34, 36 ) extending parallel to the mouth of the bag to close the sides. Preferably, a reclosable zipper seal ( 36 ) is provided below a top seal ( 34 ). A novel tag is provided, secured to the zipper seal ( 36 ) and extending through the top seal ( 34 ). The tag ( 11 ) is generally M-shaped in cross-section with its outside legs secured to the seals and with an inner tuck which the consumer can withdraw from the mouth of the bag and break open to make an access hole through the seal or seals into the interior of the bag to facilitate full opening of the mouth of the bag. Methods of manufacturing such bags are also described, particularly for use with form-fill-seal machines.
Patent DE-60032252-T2 (DE)
Inventor: MAUNSELL STEVE
IPC: D06F39/14
Filed: 2000-10-05
Granted: 2007-04-26
Abstract: A dishwasher (200) is disclosed which is suitable for mounting within a cavity under a bench (1). The dishwasher is chassis less and includes no outer wrapper or cabinet and as such is mounted directly to the cavity (301). Also disclosed are a number of embodiments relating to mechanisms for closing the lid (217) on the retractable drawer wash system and various methods for sealing the lid onto the wash drawer (201).
Patent DE-60034056-T2 (DE)
Inventor: SUTHERLAND NEIL
IPC: C23C4/00
Filed: 2000-10-20
Granted: 2007-12-06
Abstract: An improved mould (10) for use in the production of glass containers such as bottles, jars and the like, the mould (10) includes at least one mould surface defining a cavity (14) which is adapted to receive molten glass, and in which the mould (10) surface is provided with a coating (16) over substantially the whole of the surface, the coating comprising an alloy. The mould (10) is made of segments or partial sections - preferably of two half bodies (12 12a) - with a hollow space (14) in each segment or half body (12, 12a). In the hollow space (14) the coating (16) - comprising an alloy of cobalt and nickel - is metallurgically bonded to the mould (10). The process for producing the mould (10) includes that the coating (16) is fused to the mould (10) by using a two-stage process in which a powder containing the constituent elements of the alloy coating (16) is initially provided, the powder comprises a specially formulated alloy powder in which each particle essentially comprises the elements of the final alloy coating (16) or the coating (16) comprises one or more different powders which maybe mixed together.
Patent DE-60036194-T2 (DE)
Inventor: DAVIS PETER DAVID
IPC: A61P9/00
Filed: 2000-01-14
Granted: 2008-05-21
Abstract: Vascular damaging agents composed of substituted 5(6)-substituted benzimidazole-2-carbamates are provided. These agents are useful in the preparation of medicaments for the treatment of diseases involving neovascularisation, particularly for the treatment of solid tumors, macular degeneration, diabetic retinopathy, rheumatoid arthritis, psoriasis, and atherosclerosis. Embodiments include a 5(6)-substituted benzimidazole-2-carbamate of formula I wherein A represents a multi-substituted alkyl group or aromatic ring.
Patent DE-60038680-T2 (DE)
Inventor: GLEAVE MARTIN
IPC: C12Q1/6886
Filed: 2000-07-19
Granted: 2009-05-07
Abstract: A method is provided for treating hormone-regulated tumors (for example, breast and prostatic tumors) in mammals, including humans, by administration of an antisense ODN which is complementary to a portion of the gene encoding IGFBP-5. Using the Shionogi tumor model in vitro and in vivo, the administration of such an ODN was shown to reduce proliferation of tumor cells, and also to delay the progression to androgen independence. Thus, treatment of prostate cancer in mammals, including humans, and delay of the progression of prostate tumors to androgen independence is accomplished by administering to the mammal a therapeutically effective amount of an antisense oligodeoxynucleotide which is complementary to a portion of the nucleic acid sequence encoding IGFBP-5 and which hybridizes with such a sequence to inhibit expression of IGFBP-5. Specific antisense ODN's which are suitable for use in the method are GACCACGCTGATCACCAT (Seq. ID. No. 1), which is derived from the murine gene sequence, and CGCGGTGAGCAACACCAT (Seq. ID. No. 3) and AGGTCATGCAGCAGCCGC (Seq. ID No 4), which are derived from the human gene sequence.
Patent DE-60105856-T2 (DE)
Inventor: GOIKOETXEA LARRINAGA JOSU
IPC: H01J37/32
Filed: 2001-03-27
Granted: 2005-10-20
Abstract: Incorporating an anode (1) and a cathode or target (2), from which is obtained the evaporated material which will be applied to piece (10) to be coated within a vacuum chamber, and where with a magnetic guide it is endeavoured that the action of the electric arc on the target be displaced over the whole surface thereof, in a homogeneous way, the aforementioned magnetic guide is constituted by means of two independent magnetic systems, a first magnetic system constituted by a group of permanent magnets (3) located on the periphery of the cathode or target (2), in a disposition noticeably coplanar with the same, so that magnetization thereof is perpendicular to the surface of said target (2), and a second magnetic system constituted by an electromagnet (4-5), located in the rear part of target (2), housed in electrically insulating body (6) of the evaporator and at a certain distance from said target (2), with at least one of its magnetic poles parallel to the surface of said target (2), so that the combined action of the two magnetic systems determines uniform use or consumption of target (2), at the same time as an increased reliability of the evaporator. <IMAGE>
Patent DE-60115349-T2 (DE)
Inventor: ADEOKUN MONISOLA
IPC: C12Q1/6825
Filed: 2001-08-17
Granted: 2006-08-10
Abstract: This invention relates to polymorphisms in the human OATPC gene and corresponding novel allelic polypeptides encoded thereby. The invention also relates to methods and materials for analysing allelic variation in the OATPC gene, and to the use of OATPC polymorphism in treatment of diseases with OATPC transportable drugs such as statins.
Patent DE-60116625-T2 (DE)
Inventor: HORROBIN DAVID FREDERICK
IPC: A61P31/04
Filed: 2001-06-20
Granted: 2006-12-14
Abstract: Eicosapentaenoic acid or any appropriate derivative (EPA) is disclosed in combination with arachidonic acid (AA) or an AA precursor, selected from DGLA and GLA, to give a pharmaceutical formulation.
Patent DE-60127314-T2 (DE)
Inventor: HAASE KARL
IPC: A61B8/06
Filed: 2001-06-21
Granted: 2007-12-20
Abstract: The present invention provides for methods of using guide wires adapted for passage across a heart valve. The guide wires have an increased diameter and a shorter, relatively floppy distal tip; the increased diameter providing improved pushability to facilitate positioning in a blood jet and passage through a heart valve. The distal tip comprises a section of rectangular cross-section that, in conjunction with the decreased tip length, causes the distal tip to vibrate, or “dance”, when positioned within a blood jet at the outlet of a heart valve. This vibratory motion may be used to position the distal tip within the blood jet, thus facilitating passage through the valve without damage to leaflets of the valve or emboli generation.
Patent DE-60204916-T2 (DE)
Inventor: CLARINGBURN RICHARD
IPC: H04B10/2581
Filed: 2002-12-17
Granted: 2005-12-22
Abstract: An optical network node for an n-channel dense wavelength division multiplexing (DWDM) optical communications network, includes an add path for adding an n-channel wavelength multiplex onto the network. The add path has an n-channel signal combiner for combining the n signal channels. An optical amplifier amplifies an output of the signal combiner. A multichannel wavelength selective filter with variable-per-channel attenuation filters out noise from the amplifier on a channel which carries no content to be added to the network, and controls amplitude of signals in channels to be added to the network. An add coupler couples the add path to the network.